To better understand the mechanism by which the combination therapy affected MYCN protein ubiquitination, we performed a comparative Stable Isotope Labelling with Amino acids in Cell culture (SILAC) assay on total cellular protein from neuroblastoma cells treated with either DMSO, SAHA, SE486-11, or the combination. This evidence concerns the gene MYCN and neuroblastoma.